< Back to previous page
Researcher
Xavier Bossuyt
- Disciplines:Autoimmunity
Affiliations
- Clinical and Diagnostic Immunology (Lab)
Responsible
From1 Jan 2019 → Today - Clinical and Diagnostic Immunology (Lab)
Member
From1 Jan 2012 → Today - Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
1 - 10 of 34
- New methodological approaches in clinical laboratory immunologyFrom7 Feb 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ReNewAtheroFrom1 Apr 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Closing the seronegative gap in rheumatoid arthritis diagnosis using B-cell receptor sequencing combined with mass spectrometric analysis of complementarity determining regions.From1 Oct 2023 → 30 Sep 2025Funding: Other federal public and semi-governmental institutions
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVDFrom1 Oct 2023 → TodayFunding: HORIZON.3.1 - European Innovation Council (EIC)
- Why dose lung damage sometimes continue to worsen after the body seems to have cleared the SARS-CoV-2 virus?From1 Oct 2021 → 31 Mar 2023Funding: Foreign private sponsor - undefined
- Mass spectrometry based immunoprofiling in rheumatoid arthritis patientsFrom1 Oct 2021 → 18 Aug 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
- Targeted mass spectrometry-based quantification of autoantibodies in systemic rheumatic diseasesFrom1 Oct 2021 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- Tumor necrosis factor Receptor-Associated Factors in signal transduction and susceptibility to infection.From9 Aug 2021 → 9 Aug 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 338
- Extended verification of an automated MALDI-TOF mass spectrometry system for high throughput serum M-protein measurement(2025)Published in: Clinical Chemistry And Laboratory MedicineISSN: 1434-6621
- Mass spectrometry-based analysis of rheumatoid factor(2025)Published in: Frontiers in ImmunologyISSN: 1664-3224Volume: 16
- Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome(2025)Published in: JOURNAL OF THROMBOSIS AND HAEMOSTASISISSN: 1538-7933Issue: 8Volume: 23Pages: 2584 - 2597
- Detection of Anti-RuvBL1/2 Autoantibodies by Targeted Liquid Chromatography-Tandem Mass Spectrometry(2025)Published in: J Appl Lab MedISSN: 2576-9456Issue: 4Volume: 10Pages: 820 - 832
- The TFIID complex is a new autoantibody target in systemic sclerosis.(2025)Published in: ANNALS OF THE RHEUMATIC DISEASESISSN: 0003-4967Pages: S0003-4967
- Sjögren's disease with mixed cryoglobulinemia presenting as a hypertensive emergency with thrombotic microangiopathy: a diagnostic puzzle(2025)Published in: ACTA CLINICA BELGICAISSN: 1784-3286Issue: 3Volume: 80Pages: 54 - 61
- ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung disease(2025)Published in: Autoimmunity ReviewsISSN: 1568-9972Issue: 5Volume: 24
- Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based review(2025)Published in: Rheumatology InternationalISSN: 0172-8172Issue: 5Volume: 45
- BENTA disease or CARD11 gain-of-function? A novel variant with atypical features and a literature review.(2025)Published in: Immunology LettersISSN: 0165-2478Volume: 275Pages: 107005
- The EuroFlow PIDOT external quality assurance scheme: enhancing laboratory performance evaluation in immunophenotyping of rare lymphoid immunodeficiencies(2025)Published in: Clinical Chemistry And Laboratory MedicineISSN: 1434-6621Issue: 3Volume: 63Pages: 621 - 635
Patents
1 - 1 of 1